Johnson & Johnson vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Johnson & Johnson trades at $250.66 (market cap $598.96B), while iShares 10 20 Year Treasury Bond ETF trades at $97.83. The key difference: Johnson & Johnson pays a 2.15% dividend while iShares 10 20 Year Treasury Bond ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| JNJ | TLH | |
|---|---|---|
Market Cap | $598.96B | — |
Volume | 6,156,228 | — |
Sector | Health | Fixed Income |
52-Week High | $267.24 | $105.36 |
52-Week Low | $164.36 | $97.13 |
Enterprise Value | $631.90B | — |
Dividend Yield | 2.15% | — |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →